Chromosomal aberrations in lymphocytes of pharmaceutical factory workers. 1986

K Pushpavathi, and M H Prasad, and P P Reddy

Chromosomes were analyzed in peripheral lymphocytes of 31 male workers who were exposed to sulfonamide drugs in a pharmaceutical factory. The number of cells with structural chromosomal aberrations was significantly increased as compared to 15 unexposed individuals (controls). The chromosomal damage observed was mainly gaps and breaks.

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D004345 Drug Industry That segment of commercial enterprise devoted to the design, development, and manufacture of chemical products for use in the diagnosis and treatment of disease, disability, or other dysfunction, or to improve function. Industries, Pharmaceutic,Industry, Drug,Industry, Pharmaceutic,Industry, Pharmaceutical,Pharmaceutical Industry,Drug Industries,Industries, Drug,Industries, Pharmaceutical,Pharmaceutic Industries,Pharmaceutic Industry,Pharmaceutical Industries
D004781 Environmental Exposure The exposure to potentially harmful chemical, physical, or biological agents in the environment or to environmental factors that may include ionizing radiation, pathogenic organisms, or toxic chemicals. Exposure, Environmental,Environmental Exposures,Exposures, Environmental
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013449 Sulfonamides A group of compounds that contain the structure SO2NH2. Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide

Related Publications

K Pushpavathi, and M H Prasad, and P P Reddy
October 1997, Mutation research,
K Pushpavathi, and M H Prasad, and P P Reddy
January 2010, Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases,
K Pushpavathi, and M H Prasad, and P P Reddy
January 2010, Environmental toxicology and pharmacology,
K Pushpavathi, and M H Prasad, and P P Reddy
February 2022, Anticancer research,
K Pushpavathi, and M H Prasad, and P P Reddy
January 1984, Human heredity,
K Pushpavathi, and M H Prasad, and P P Reddy
November 1984, Carcinogenesis,
K Pushpavathi, and M H Prasad, and P P Reddy
June 1989, Environmental research,
K Pushpavathi, and M H Prasad, and P P Reddy
September 1988, Mutation research,
K Pushpavathi, and M H Prasad, and P P Reddy
January 1982, Hereditas,
Copied contents to your clipboard!